ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combination With Ipi for People With Ovarian and Other Extra-Renal CCCs Who Had Relapsed After Prior Therapy"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combination With Ipi for People With Ovarian and Other Extra-Renal CCCs Who Had Relapsed After Prior Therapy"

By ecancer FEATURING Don Dizon

104 views

June 21, 2024

Comments 0

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn

2024 ASCO® Annual Meeting Insights Hub: GYN Videos

ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in …

2024 ASCO® Annual Meeting Insights Hub

J. Classe

145 views

4 months ago

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

1.6K views

4 months ago

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

421 views

4 months ago

View All

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

1.6K views

4 months ago

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.4K views

5 months ago

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

7 months ago

Cancer Screening Molecular Tools

Fengting Yan

2.5K views

11 months ago

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

1.0K views

5 months ago

Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

543 views

1 month ago

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

2024 ESMO Annual Meeting Insights Hub

B. Monk

442 views

2 months ago

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

326 views

2 months ago

2024 Updates in Ovarian Cancer

Total Health

T. Tillmanns

436 views

8 months ago

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

421 views

4 months ago

SGO 2024 Summary: "Key Updates in Endometrial Cancer"

Insights from 2024 SGO Annual Meeting

M. Raza Mirza

509 views

6 months ago

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

2024 ESMO Annual Meeting Insights Hub

B. Slomovitz

220 views

1 month ago

Defining Platinum Resistance in Ovarian Cancer

Michael Birrer

534 views

6 months ago

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan

439 views

5 months ago

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification With a…

Insights from 2024 SGO Annual Meeting

A. Clements

502 views

7 months ago

2024 Updates in Cervical Cancer

Total Health

T. Tillmanns

499 views

8 months ago

Updates in the Management of Cervical Cancer

Abdulrahman Sinno

381 views

2 months ago

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill

218 views

2 months ago

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Insights from 2023 ESMO Annual Meeting

M. Raza Mirza

1.0K views

1 year ago

SGO 2024 Endometrial Cancer Highlights

Insights from 2024 SGO Annual Meeting

P. Binder

292 views

3 months ago

AUTOPLAY

Login

Login

Join VuMedi

ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combination With Ipi for People With Ovarian and Other Extra-Renal CCCs Who Had Relapsed After Prior Therapy"

The Role Of Folate Receptor Alpha In Ovarian Cancer

Management Strategies for Fatigue and Asthenia in First-line Mainten…

2024 ASCO® Annual Meeting Insights Hub: GYN Videos

ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in …

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

Recommended

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Cancer Screening Molecular Tools

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

Recent FDA Indications in Endometrial Cancers

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 Updates in Ovarian Cancer

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

SGO 2024 Summary: "Key Updates in Endometrial Cancer"

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

Defining Platinum Resistance in Ovarian Cancer

Management of Recurrent Ovarian Clear Cell Carcinoma

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification With a…

2024 Updates in Cervical Cancer

Updates in the Management of Cervical Cancer

Endometrial Cancer: The Current Treatment Landscape

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

SGO 2024 Endometrial Cancer Highlights